Webinar

Improving Access to Medicines: A Framework for Pricing and Patient Access Decisions in Low and Middle Income Countries (LMICs)

March 22, 2017 1:00 PM - 2:00 PM GMT

As LMICs move towards Universal Health Coverage, decisions on health services and medicines coverage of emerging and expanding insurance systems are becoming increasingly important. A key challenge for improving access to medicines is determining which medicines to reimburse, for which patients, and...

More detail »

Translating Evidence to Policy: Who? Where? Why? And what does it mean for my research?

October 26, 2016, 9am - 10am EST

On October 26, from 9-10 AM EDT, Health Systems Global’s  Translating Evidence to Action Working Group  hosted a webinar introducing the  Baseline Inventory of Global Initiatives for Knowledge Translation . The inventory, compiled in collaboration with the  SHAPES  TW...

More detail »

Calling all HPSR Teachers and Learners—Get involved with a mentorship and peer exchange opportunity in Vancouver!

October 18, 2016, 8am - 9am EST

We know how important teaching and learning HPSR is, and many of us get to see materials from the courses of our colleagues and hear about the experiences of global leaders like CHEPSAA, ARCADE, KEYSTONE and others. Yet, we seldom get the opportunity for one-on-one mentorship and peer exchange to pr...

More detail »

HPSR Reader on Human Resources for Health: Webinar for feedback on initiative, proposed structure and next steps

September 30, 2016, 9am EST

Overview On 1 August 2016, we posted a blog on Health Systems Global launching work on a reader that supports health policy and systems research on human resources for health. Since then, 40 peers responded enrolling in various steps in the development of the reader, with 18 colleagues providing inp...

More detail »

Access to novel, highly-priced cancer medicines in low-resource settings – ethical challenges on the path to Universal Health Coverage

October 12th, 2016, 8am - 9am EDT

Overview Safe, affordable access to novel cancer medicines is desirable in all health care systems. In most systems, however, funding of access to highly priced cancer medicines competes with funding of health care for other needs. Based on two recommendations of the World Health Organization, we wi...

More detail »